Business | Press Trust of India | Monday March 28, 2016
Biocon has received approval from the Japanese health authority to sell its biosimilar product 'Insulin Glargine' in that country. The Ministry of Health, Labour and Welfare (MHLW) of Japan has approved the sale of Glargine, a significant achievement for Biocon and its commercial partner, Fujifilm Pharma, the biotech major said in a filing to BSE.
www.ndtv.com/business